Rich Ice Cream Co., a Florida-based ice cream manufacturer, is in the midst of a substantial recall with more than 100,000 ice cream bars potentially tainted with listeria monocytogenes. Click2Houston reports that the company initiated the recall on June 27, after which the U.S. Food and Drug Administration made an announcement on July 17. Across 23 states, ice cream bars ranging from Chocolate Crunch Cake Bar to Cool Watermelon Bar are being pulled from shelves to mitigate risk.
This recall is classified as Class II, which involves situations "in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." Such a classification suggests that while the health risks are generally contained, customers are still advised to exercise caution and check their recent purchases. Consumers may have to quickly identify and return or dispose of any products they have purchased across a range of lot numbers from 24351 through 25156. NBC Los Angeles detailed the ten ice cream products involved in this recall.
Listeria monocytogenes is known for being particularly tenacious, capable of growing in refrigeration and posing serious health risks such as listeriosis, a potentially fatal infection. According to NBC Los Angeles, it's the third leading cause of death from foodborne illness in the United States. States affected include Texas, California, New York, and 20 others, and even Nassau, the capital of The Bahamas, may see impacted cases.
Rich's Ice Cream Co. has yet to release a statement on potential remedies for customers who have purchased the recalled items, leaving many awaiting guidance on next steps. In the meantime, consumers should examine their freezers to ensure they do not inadvertently consume any contaminated products. Those worried about health implications should consult a healthcare provider, particularly if symptoms of listeriosis arise. For the most current information, it is advised to follow FDA updates and directives.
